People | January 07, 2022
Barentz appoints Daniel Hitz as CEO, APAC
Hitz shall assume new role from January 17th, 2022
Hitz shall assume new role from January 17th, 2022
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
Filing marks first protein-based vaccine submitted to MHRA for authorization
Support from DFC will help produce one billion vaccine doses by the end of 2022
Key takeaways of recent quarter & conference call highlights
Subscribe To Our Newsletter & Stay Updated
